Medicinal chemistry in drug discovery involves the intricate process of conceiving and developing new medicines. While this journey is lengthy, complex, expensive, and risky, the potential benefits for millions of patients with serious illnesses serve as a constant driving force.
Aryastha Life Sciences specializes in drug discovery and development services, harnessing the power of established cell line, primary cells from diseased organs, and in vivo models, including syngeneic and cell/tissue-derived systems.
Aryastha provides a comprehensive range of services encompassing in vitro ADME, toxicity (in vitro ADMET), and in vivo pharmacokinetics (PK), offering rapid evaluations of test articles DMPK properties and toxicity.
The journey of a drug substance through medicinal chemistry rarely concludes with an ultimate production route. Scaling a drug substance from milligrams to kilograms entails much more.
Integrated programs with pharma/biotech companies
IND's
Clinical assets
(Phase 1, 2 & 3)
Patents & Publications
SQFT of dedicated R&D center
Analytical & ancillary support
State of the art analytical instrumentation to speed the analysis and purification process
Owned by the client
Restricted role-based
access control to ensure IP protection and confidentiality of client programs
Secured IT infrastructure
with multi-factor authentication in place to protect against any cyber threats
Ability to quickly scale-up infrastructure and skilled
manpower as per client
requirement.
Flexible business models